Value of information analysis in oncology: The value of evidence and evidence of value

Journal of Oncology Practice

Volumn 10, Issue 2, 2014, Pages

  Tuffaha, Haitham W ^a   Gordon, Louisa G ^a   Scuffham, Paul A ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; BREAST CANCER; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; HEALTH CARE; HEALTH CARE SYSTEM; HUMAN; INFORMATION PROCESSING; LUNG CANCER; MEDICAL DECISION MAKING; ONCOLOGY; PROSTATE CANCER; RESEARCH PRIORITY; REVIEW; SYSTEMATIC REVIEW; VALUE OF INFORMATION; COST BENEFIT ANALYSIS; DECISION MAKING; HEALTH CARE DELIVERY; MEDICAL INFORMATICS; MEDICAL RESEARCH; META ANALYSIS; METHODOLOGY; STANDARDS;

BIOMEDICAL RESEARCH; COST-BENEFIT ANALYSIS; DECISION MAKING; DELIVERY OF HEALTH CARE; HUMANS; MEDICAL INFORMATICS; MEDICAL ONCOLOGY; RESEARCH DESIGN;

EID: 84900867622     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2013.001108     Document Type: Review

References (59)

1. Lyman GH, Levine M: Comparative effectiveness research in oncology: An overview. J Clin Oncol 30:4181-4184, 2012
2. Briggs AH, Weinstein MC, Fenwick EA, et al: Model parameter estimation and uncertainty: A report of the ISPOR-SMDM Modeling Good Research Practices Task Force 6. Value Health 15:835-842, 2012
3. Claxton K: Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics 26:781-798, 2008
4. Eckermann S, Karnon J, Willan AR: The value of value of information best informing research design and prioritization using current methods. Pharmacoeconomics 28:699-709, 2010
5. Claxton KP, Sculpher MJ: Using value of information analysis to prioritise health research: Some lessons from recent UK experience. Pharmacoeconomics 24:1055-1068, 2006 (Pubitemid 44683363)
6. Felli JC, Hazen GB: Sensitivity analysis and the expected value of perfect information. Med Decis Making 18:95-109, 1998 (Pubitemid 28041646)
7. Claxton K, Posnett J: An economic approach to clinical trial design and research priority-setting. Health Econ 5:513-524, 1996
8. Fenwick E, Claxton K, Sculpher M: The value of implementation and the value of information: Combined and uneven development. Med Decis Making 28:21-32, 2008
9. Willan AR, Eckermann S: Optimal clinical trial design using value of information methods with imperfect implementation. Health Econ 19:549-561, 2010
10. Hoomans T, Fenwick EAL, Palmer S, et al: Value of information and value of implementation: Application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer. Value Health 12:315-324, 2009
11. Basu A, Meltzer D: Value of information on preference heterogeneity and individualized care. Med Decis Making 27:112-127, 2007 (Pubitemid 46568909)
12. van Gestel A, Grutters J, Schouten J, et al: The role of the expected value of individualized care in cost-effectiveness analyses and decision making. Value Health 15:13-21, 2012
13. Steuten L, van de Wetering G, Groothuis-Oudshoorn K, et al: A systematic and critical review of the evolving methods and applications of value of information in academia and practice. Pharmacoeconomics 31:25-48, 2013
14. PRISMA: Transparent reporting of systematic reviews and meta-analyses. http://www.prisma-statement.org
15. Brown J, Welton NJ, Bankhead C, et al: A Bayesian approach to analysing the cost-effectiveness of two primary care interventions aimed at improving attendance for breast screening. Health Econ 15:435-445, 2006
16. Brush J, Boyd K, Chappell F, et al: The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: A systematic review and economic evaluation. Health Technol Assess 15:1-192, 2011
17. Carlson JJ, Garrison LP, Ramsey SD, et al: The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer. Value Health 12:20-27, 2009
18. Carlson JJ, Thariani R, Roth J, et al: Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: An application in cancer genomics. Med Decis Making 33:463-471, 2013
19. Castelnuovo E, Thompson-Coon J, Pitt M, et al: The cost-effectiveness of testing for hepatitis C in former injecting drug users. Health Technol Assess 10:1-93, 2006
20. Collins R, Fenwick E, Trowman R, et al: A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer. Health Technol Assess 11:1-179, 2007
21. Grutters JP, Pijls-Johannesma M, Ruysscher DD, et al: The cost-effectiveness of particle therapy in non-small cell lung cancer: Exploring decision uncertainty and areas for future research. Cancer Treat Rev 36:468-476, 2010
22. Hall PS, Hulme C, McCabe C, et al: Updated cost-effectiveness analysis of trastuzumab for early breast cancer: A UK perspective considering duration of benefit, long-term toxicity and pattern of recurrence. Pharmacoeconomics 29: 415-432, 2011
23. Hall PS, Hulme C, McCabe C, et al: Updated cost-effectiveness analysis of trastuzumab for early breast cancer: A UK perspective considering duration of benefit, long-term toxicity and pattern of recurrence. Pharmacoeconomics 29: 415-432, 2011
24. Hassan C, Hunink MG, Laghi A, et al: Value-of-information analysis to guide future research in colorectal cancer screening. Radiology 253:745-752, 2009
25. Hassan C, Pickhardt PJ, Laghi A, et al: Impact of whole-body CT screening on the cost-effectiveness of CT colonography. Radiology 251:156-165, 2009
26. Havrilesky LJ, Chino J, Myers ER: How much is another randomized trial of lymph node dissection in endometrial cancer worth? A value of information analysis. Gynecol Oncol [epub ahead of print on June 22, 2013]
27. Karnon J: Planning the efficient allocation of research funds: An adapted application of a non-parametric Bayesian value of information analysis. Health Policy 61:329-347, 2002
28. Kee F, Erridge S, Bradbury I, et al: The value of positron emission tomography in patients with non-small cell lung cancer. Eur J Radiol 73:50-58, 2010
29. Lee RC, Ekaette E, Kelly KL, et al: Implications of cancer staging uncertainties in radiation therapy decisions. Med Decis Making 26:226-238, 2006 (Pubitemid 43726008)
30. Lu L, Peters J, Roome C, et al: Cost-effectiveness of alemtuzumab for T-cell prolymphocytic leukemia. Int J Technol Assess Health Care 28:241-248, 2012
31. Martikainen JA, Kivioja A, Hallinen T, et al: Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme. Pharmacoeconomics 23:803-815, 2005 (Pubitemid 41420427)
32. Purmonen TT, Pänkäläinen E, Turunen JH, et al: Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial. Acta Oncol 50:344-352, 2011
33. Rao C, Haycock A, Zacharakis E, et al: Economic analysis of esophageal stenting for management of malignant dysphagia. Dis Esophagus 22:337-347, 2009
34. Retèl VP, van der Molen L, Hilgers FJM, et al: A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy. BMC Cancer 11:475-482, 2011
35. Rojnik K, Naversnik K: Gaussian process metamodeling in Bayesian value of information analysis: A case of the complex health economic model for breast cancer screening. Value Health 11:240-250, 2008 (Pubitemid 351473618)
36. Søgaard R, Fischer BM, Mortensen J, et al: The optimality of different strategies for supplemental staging of non-small-cell lung cancer: A health economic decision analysis. Value Health 16:57-65, 2013
37. Soini EJ, García San Andrés B, Joensuu T: Trabectedin in the treatment of metastatic soft tissue sarcoma: Cost-effectiveness, cost-utility and value of information. Ann Oncol 22:215-223, 2011
38. Soini EJ, Martikainen JA, Nousiainen T: Treatment of follicular non-Hodgkin's lymphoma with or without rituximab: Cost-effectiveness and value of information based on a 5-year follow-up. Ann Oncol 22:1189-1197, 2011
39. Soini EJ, Martikainen JA, Vihervaara V, et al: Economic evaluation of sequential treatments for follicular non-Hodgkin lymphoma. Clin Ther 34:915-925, 2012
40. Somerville M, Garside R, Pitt M, et al: Surveillance of Barrett's oesophagus: Is it worthwhile? Eur J Cancer 44:588-599, 2008
41. Speight PM, Palmer S, Moles DR, et al: The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess 10:1-144, 2006
42. Welton NJ, Ades AE, Caldwell DM, et al: Research prioritization based on expected value of partial perfect information: A case-study on interventions to increase uptake of breast cancer screening. JR Stat Soc A 171:807-841, 2008
43. Willan A, Kowgier M: Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods. Clin Trials 5:289-300, 2008
44. Willan AR, Pinto EM: The value of information and optimal clinical trial design. Stat Med 24:1791-806, 2005 (Pubitemid 40872643)
45. Wilson EC, Emery JD, Kinmonth AL, et al: The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: A decision-analytic model. Value Health 16:356-366, 2013
46. Wong WB, Ramsey SD, Barlow WE, et al: The value of comparative effectiveness research: Projected return on investment of the RxPONDER trial (SWOG S1007). Contemp Clin Trials 33:1117-1123, 2012
47. Woods B, Veenstra D, Hawkins N: Prioritizing pharmacogenetic research: A value of information analysis of CYP2D6 testing to guide breast cancer treatment. Value Health 14:989-1001, 2011
48. Hanemann WM: Information and the concept of option value. J Environ Econ Manage 16:23-37, 1989
49. Yokota F, Thompson KM: Value of information literature analysis: A review of applications in health risk management. Med Decis Making 24:287-298, 2004 (Pubitemid 38656313)
50. Claxton K, Palmer S, Longworth L, et al: Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Health Technol Assess 16:1-323, 2012
51. Conti S, Claxton K: Dimensions of design space: A decision-theoretic approach to optimal research design. Med Decis Making 29:643-660, 2009
52. Griffin S, Welton NJ, Claxton K: Exploring the research decision space: The expected value of information for sequential research designs. Med Decis Making 30:155-162, 2010
53. Groot Koerkamp B, Nikken JJ, Oei EH, et al: Value of information analysis used to determine the necessity of additional research: MR imaging in acute knee trauma as an example. Radiology 246:420-425, 2008
54. Koerkamp BG, Spronk S, Stijnen T, et al: Value of information analyses of economic randomized controlled trials: The treatment of intermittent claudication. Value Health 13:242-250, 2010
55. Soares MO, Dumville JC, Ashby RL, et al: Methods to assess cost-effectiveness and value of further research when data are sparse: Negative-pressure wound therapy for severe pressure ulcers. Med Decis Making 33:415-436, 2012
56. Stevenson MD, Jones ML: The cost effectiveness of a randomized controlled trial to establish the relative efficacy of vitamin K1 compared with alendronate. Med Decis Making 31:43-52, 2011
57. Fleurence RL: Setting priorities for research: A practical application of payback and expected value of information. Health Econ 16:1345-1357, 2007
58. Davies L, Drummond M, Papanikolaou P: Prioritizing investments in health technology assessment: Can we assess potential value for money? Int J Technol Assess Health Care 16:73-91, 2000 (Pubitemid 30263204)
59. Myers E, Sanders GD, Ravi D, et al: Evaluating the potential use of modeling and value-of-information analysis for future research prioritization within the evidence-based practice center program. http://effectivehealthcare. ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?productid= 700&pageaction=displayproduct